Executive Summary
| Informations | |||
|---|---|---|---|
| Name | CVE-2025-0416 | First vendor Publication | 2025-04-01 |
| Vendor | Cve | Last vendor Modification | 2025-04-01 |
Security-Database Scoring CVSS v3
| Cvss vector : N/A | |||
|---|---|---|---|
| Overall CVSS Score | NA | ||
| Base Score | NA | Environmental Score | NA |
| impact SubScore | NA | Temporal Score | NA |
| Exploitabality Sub Score | NA | ||
| Calculate full CVSS 3.0 Vectors scores | |||
Security-Database Scoring CVSS v2
| Cvss vector : | |||
|---|---|---|---|
| Cvss Base Score | N/A | Attack Range | N/A |
| Cvss Impact Score | N/A | Attack Complexity | N/A |
| Cvss Expoit Score | N/A | Authentication | N/A |
| Calculate full CVSS 2.0 Vectors scores | |||
Detail
| Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system. |
Original Source
| Url : http://cve.mitre.org/cgi-bin/cvename.cgi?name=CVE-2025-0416 |
Sources (Detail)
| Source | Url |
|---|
Alert History
| Date | Informations |
|---|---|
| 2025-05-27 02:50:26 |
|
